AzTrials
AzTrials

Acute DyspneaREADNCT02531542

Evaluation of Rapid Emergency Echography for Acute Dyspnoea

A study testing Echocardiography according to the READ method. in people with Acute Dyspnea, run by Centre Hospitalier Universitaire de Besancon at 5 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Elderly people constitute the largest proportion of emergency room patients, representing 12% of all emergency room admissions. The need for diagnostic tests or therapeutic interventions is much greater in this patient population. Read more about this study

Who is it for?
Ages 75 years and older
Conditions the study is for
Acute Dyspnea
What is being tested?
Echocardiography according to the READ method.
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
461 participants
Where
5 sitesFrance
Study dates
29 Feb 2016to 27 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Admission to the Emergency Department Age ≥ 75 years
  • AND criteria of acute dyspnoea:
  • Breathe rate ≥ 25 cycles/minute
  • or PaO2 ≤ 70 mmHg
  • or SpO2 ≤ 92% in room air
  • or PacO2 ≥ 45 mmHg and pH ≤ 7.35 AND Electrocardiogram in sinus rhythm or in atrial fibrillation at admission

Who cannot join

  • Shock i.e. : systolic arterial pressure <90mmHg; or reduction >40mmHg or >30% of usual arterial pressure; or Mean Arterial Pressure <65mmHG.
  • Acute respiratory distress ie : Respiratory rate >30cpm, use of accessory respiratory muscles, SpO2 <90% when O2 therapy is required, impaired consciousness,
  • Presence of acute coronary syndrome on the ECG
  • Other obvious etiological diagnosis (pneumothorax, clinical and radiological manifestations of pneumonia)
  • Cardiological or respiratory medicine therapies initiated before the READ approach could be put in place (at patient's home, pre-hospital and/or in the emergency department) i.e.. diuretic, vasoactive drugs (nitrovasodilator, sympathomimetic and cardiotonic drugs, vasodilators and vasoconstrictors); or Continuous Positive Airway Pressure (CPAP); or invasive or non-invasive ventilation.
  • Patient not affiliated to or beneficiary of the French social security system
  • Protected people (pregnant and lactating women, guardianship, curatorship, under the protection of justice)Subjects in the exclusion period after participation in another clinical trial, or as listed in the national database of health research volunteers

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

France5 sites
  • University Hospital of Clermont-Ferrand

    Clermont-Ferrand, Auvergne, 63000

  • Centre hospitalier de Pau

    Pau, New Aquitaine, 64000

  • University Hospital of Strasbourg

    Strasbourg, Grand Est, 67000

  • Centre Hospitalier de Toulon

    Toulon, Provence-Alpes-Côte d'Azur Region, 83000

  • University Hospital of Toulouse

    Toulouse, Occitanie, 31000

Other trials in France

About this study

Official title: Evaluation of Rapid Emergency Echography for Acute Dyspnoea for the Diagnosis of Acute Left-sided Heart Failure in Elderly Subjects Admitted to the Emergency Room (READ Protocol)

Elderly people constitute the largest proportion of emergency room patients, representing 12% of all emergency room admissions. The need for diagnostic tests or therapeutic interventions is much greater in this patient population. Cardiovascular diseases and symptoms represent 12% of the causes for emergency room admission, and patients suffering from cardiovascular disease are those whose emergency room visit lasts longest.

The diagnostic approach in the emergency room in elderly patients admitted for acute dypsnoea is complex, and early identification of acute left-sided heart failure (ALSHF) is vital as it has an impact on prognosis. The clinical signs are difficult to interpret, and are non-specific, particularly at the acute phase and in elderly or obese patients. Indeed, some authors have reported up to 50% of diagnostic errors in elderly patients.

Read more

Measure of the blood concentration of a natriuretic peptide allows a quick diagnosis. However, peptides suffer from several limitations, particularly in situations that are often encountered in elderly patients, such as sepsis, renal failure, acute coronary syndrome, pulmonary embolism, chronic respiratory failure, atrial fibrillation and high body mass index. Diagnostic performance deteriorates with increasing age, and there is a significant increase in this grey-zone in patients aged ≥75 years. In critical situations in elderly patients, assessment of natriuretic peptides serve mainly to rule out a diagnosis of left heart failure.

Some authors have suggested using lung ultrasound in the initial work-up of acute respiratory failure, since some specific profiles are known to be related to the presence of interstitial oedema, reflecting impaired left heart function (e.g. presence of B lines). These studies were performed in the context of intensive or critical care, but data are sparse regarding the application of this approach in the emergency room.

The hypothesis is that the diagnostic accuracy of a targeted and quick echographic approach, namely the READ method (Rapid Echography for Acute Dyspnoea), comprising targeted lung ultrasound combined with isolated measure of transmitral flow, would be superior to that of NT-proBNP assessment for the diagnosis of ALSHF in elderly patients (≥75 years) admitted to the emergency department.

Read the detailed description

The number of emergency room visits is constantly increasing, and it is therefore necessary to minimize the duration of each visit, thereby increasing the efficacy of the diagnostic process, leading to quicker orientation of each patient for appropriate care. In this context, accurate triage and a quick initial diagnostic work-up are of paramount importance in achieving this goal.

Elderly people constitute the largest proportion of emergency room patients, representing 12% of all emergency room admissions. The need for diagnostic tests or therapeutic interventions is much greater in this patient population, with 4 out of 5 patients requiring such measures. Indeed, elderly persons often suffer from multiple diseases that require a greater number of tests (source: Direction de la recherche, des études, de l'évaluation et des statistiques (DREES), emergency room survey) (1).

Cardiovascular diseases and symptoms represent 12% of the causes for emergency room admission, and patients suffering from cardiovascular disease are those whose emergency room visit lasts longest. Indeed, almost 50% of patients with cardiovascular disease stay more than 4 hours in the emergency room, according to a French national survey published in July 2014.

The diagnostic approach in the emergency room in elderly patients admitted for acute dypsnoea is complex, and early identification of acute left-sided heart failure (ALSHF) is vital as it has an impact on prognosis.

Acute dyspnoea and acute respiratory insufficiency are frequent causes of admission to the emergency room. The etiological diagnosis is difficult, especially in elderly patients who often have a history of cardio-respiratory disease (2)(3)(4)(5). In this specific population, there are often numerous comorbidities, such as chronic respiratory failure, chronic renal failure, and ischemic heart disease (6). In addition, acute respiratory insufficiency can be caused by a range of distinct pathologies, such as acute heart failure, pneumonia, exacerbation of chronic obstructive pulmonary disease (COPD), pleural effusion or pulmonary embolism. There is thus clearly a pressing need for an accurate and early diagnosis of the correct etiology in these patients, particularly to identify ALSHF, a condition that requires immediate initiation of appropriate therapy in order to improve prognosis. In these patients, studies have shown that inappropriate or delayed therapy in the emergency room is an independent predictor of death (2)(3)(7).

The European Society of Cardiology (ESC) recently published a review of the standard diagnostic methods for ALSHF, describing the advantages and limitations of each (clinical examination, electrocardiogram (ECG), chest x-ray, NT-proBNP assessment) (8).

The clinical signs are difficult to interpret, and are non-specific, particularly at the acute phase and in elderly or obese patients (9). Indeed, some authors have reported up to 50% of diagnostic errors in elderly patients (10).

Chest x-ray, which is usually performed in the emergency room, is not specific because of the conditions in which it is performed in emergency situations. Generally, the pre-requisites for proper implementation are not fully respected because of the emergency nature of the exam, and chest x-ray is therefore primarily useful for differential diagnosis only (8).

Early echocardiography is recommended in patients presenting to the hospital in an emergency with suspected heart failure (HF) and acute onset of symptoms. Imaging techniques play a central role in the diagnosis of HF and in guiding treatment. Among the several imaging modalities available, echocardiography is the method of choice in patients with suspected HF for reasons of accuracy, availability (including portability), safety and cost. The term echocardiography is used here to refer to all cardiac ultrasound imaging techniques, including two- or three-dimensional echocardiography, pulsed and continuous wave Doppler, colour flow Doppler, and tissue Doppler imaging. For assessment of left ventricular systolic and diastolic dysfunction, no single echocardiographic parameter is sufficiently accurate and reproducible to be used in isolation. Therefore, a comprehensive echocardiographic examination incorporating all relevant two-dimensional and Doppler data is recommended. This should include the evaluation of both structural and functional abnormalities.

However, this type of specialised echocardiography is not routinely available in most emergency rooms. In routine practice, systematic specialised echocardiography by a cardiologist for all cases of acute respiratory failure is not feasible due to the lack of trained operators. Indeed, training in specialised echocardiography is not a pre-requisite to become a qualified emergency room physician in France. Lastly, specialised echocardiography exams are time-consuming and incompatible with the need to manage the vast flow of patients through a busy emergency room.

An alternative approach to diagnosis is to measure the blood concentration of a natriuretic peptide, a family of hormones secreted in increased amounts when the heart is diseased or the load on any chamber is increased (11)(12)(13)(14)(15)(16). However, peptides suffer from several limitations, particularly in situations that are often encountered in elderly patients, such as sepsis, renal failure, acute coronary syndrome, pulmonary embolism, chronic respiratory failure, atrial fibrillation and high body mass index (17). Diagnostic performance deteriorates with increasing age, and there is a significant increase in this grey-zone in patients aged ≥75 years (8)(16)(18)(19). In critical situations in elderly patients, assessment of natriuretic peptides serve mainly to rule out a diagnosis of left heart failure (8)(16)(19).

Some authors have suggested using lung ultrasound in the initial work-up of acute respiratory failure (20)(21)(22)(23)(24)(25)(26), since some specific profiles are known to be related to the presence of interstitial oedema, reflecting impaired left heart function (e.g. presence of B lines) (27)(28). These studies were performed in the context of intensive or critical care, but data are sparse regarding the application of this approach in the emergency room.

In a preliminary, single-centre study, the utility of a quick transthoracic echography approach was investigated, namely the READ method (Rapid Echography for Acute Dyspnoea), which associated targeted lung ultrasound and measure of transmitral flow in 51 patients aged ≥75 years. When performed at the patient's admission to the emergency room, the READ method was showed to have a sensitivity of 95% for the identification of ALSHF. Indeed, analysis of transmitral flow is easily available by transthoracic echography. The presence of a "restrictive" pattern in case of acute dypsnoea is associated with the existence of ALSHF (29)(30)(31)(32)(33).

Echography is a diagnostic tool whose use in the emergency room is increasing exponentially. For example, the "Focused Assessment with Sonography in Trauma" (FAST) ultrasound assessment technique in trauma patients has become the cornerstone of initial triage in trauma patients. The idea is to use targeted ultrasound, not necessarily performed by a specialist, to achieve accurate triage of patients in only a few minutes to guide subsequent diagnostic and therapeutic approaches.

There is a paucity of well-conducted studies in the literature evaluating the utility of targeted chest ultrasound in the diagnostic work-up of acute dyspnoea in elderly patients admitted to the emergency department. There currently exists no consensus regarding the use of echography in these patients, and its use largely depends on the competency and availability of operators in the emergency, in the absence of formal evidence proving its utility. Biomarkers such as brain natriuretic peptide (BNP) or NT-proBNP lack sensitivity in this age-category of patients, although they are widely used in routine practice given the impossibility of rapid, and 24/7 access to specialised echocardiography.

In this context, the study hypothesis is that the diagnostic accuracy of a targeted and quick echographic approach, namely the READ method (Rapid Echography for Acute Dyspnoea), comprising targeted lung ultrasound combined with isolated measure of transmitral flow, would be superior to that of NT-proBNP assessment for the diagnosis of ALSHF in elderly patients (≥75 years) admitted to the emergency department.

Conditions
Acute Dyspnea
Being tested
Echocardiography according to the READ method.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Echocardiography according to the READ method.Device

    • Echocardiography will be performed before any therapy is initiated by a fully trained operator, according to the READ method. The results of this ultrasound will not be communicated to the clinician managing the patient in the emergency room.
    • A blood sample will be taken during the routine work-up for centralized evaluation of NT-proBNP levels.
Study groups in NCT02531542
Study groupRoleWhat they receive
READ echographyOtherNot described
Receives: Device: Echocardiography according to the READ method.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To demonstrate the superiority of the READ method over assessment of NT-proBNP for the diagnosis of acute left-sided heart failure in patients aged ≥75 years admitted to the emergency department for acute dyspnoea.

    The diagnosis of ALSHF will be established post hoc by two experts based on a specialised echocardiography performed within 7 days after inclusion, or before discharge (whichever occurs first) and on the patient's medical file.

    The presence of ALSHF using the READ method is defined as presence of diffuse B-lines on lung ultrasound, combined with a restrictive pattern on analysis of transmitral profile.

    A diagnosis of ALSHF will be retained if the NT-proBNP level is greater than the threshold value of 1800 pg/mL, which is the appropriate threshold for patients aged >75 years.

    Measured: 1 day

Secondary outcomes (3)
  1. To evaluate the utility of the combination of the READ method and assessment of NT-proBNP for the diagnosis of ALSHF.

    The diagnostic value of the test, assessed in terms of sensitivity and specificity, will be calculated based on the optimal combination of the results of the two tests, namely the READ method and NT-proBNP assessment.

    Measured: 1 day

  2. To assess the potential influence of patients characteristics (age, sex, clinical presentation) on the diagnostic performance of each method of diagnosis (READ and NT-proBNP assessment).

    We will investigate the possible presence of a spectrum effect, mainly in terms of age and gender, in the population.

    Measured: 1 day

  3. To evaluate agreement between the results of the READ approach interpreted immediately in the emergency setting, vs deferred evaluation (outside the emergency setting) of the same images by a different operator.

    We will evaluate agreement between the results of the READ approach interpreted immediately in the emergency setting, vs deferred evaluation (outside the emergency setting) of the same images by a different expert operator.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Aug 2015 (estimated)
  2. Study start29 Feb 2016
  3. Primary completion20 Dec 2022
  4. Study completion27 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
Single blind
Who is masked
Care provider
Enrolment
461 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02531542
Sponsor's protocol ID
N/2014/69
Acronym
READ
Status last verified
Jan 2025
First submitted
12 Aug 2015
Last updated
17 Jan 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Echocardiography according to the READ method. in people with Acute Dyspnea, run by Centre Hospitalier Universitaire de Besancon at 5 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To demonstrate the superiority of the READ method over assessment of NT-proBNP for the diagnosis of acute left-sided heart failure in patients aged ≥75 years admitted to the emergency department for acute dyspnoea. (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in